Phathom Pharmaceuticals, Inc. (PHAT) › Net IncomePhathom Pharmaceuticals, Inc. (PHAT) — Net IncomeAnnual figures by fiscal year, from SEC filings.2018: -$1.29M2019: -$255.13M2020: -$129.07M2021: -$143.88M2022: -$197.72M2023: -$201.59M2024: -$334.33M2025: -$221.25M-$221.25M2018Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$221.25M+33.8%2024-$334.33M-65.8%2023-$201.59M-2.0%2022-$197.72M-37.4%2021-$143.88M-11.5%2020-$129.07M+49.4%2019-$255.13M-19708.3%2018-$1.29M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share